|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Arrowhead Pharmaceuticals (NASDAQ: ARWR) through any online brokerage.
The latest price target for Arrowhead Pharmaceuticals (NASDAQ: ARWR) was reported by SVB Leerink on November 23, 2021. The analyst firm set a price target for 45.00 expecting ARWR to fall to within 12 months (a possible -36.77% downside). 8 analyst firms have reported ratings in the last year.
The stock price for Arrowhead Pharmaceuticals (NASDAQ: ARWR) is $71.17 last updated Mon Nov 29 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Arrowhead Pharmaceuticals.
Arrowhead Pharmaceuticals’s $Q1 earnings are confirmed for after-market on February 3, 2022.
There is no upcoming split for Arrowhead Pharmaceuticals.
Arrowhead Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.